Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0205700 (
ash
)
15,125
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dichloromethylene diphosphonate (Cl2MDP) was given at doses of 4 mg/kg and 10 mg/kg daily for 7 days to adult thyroparathyroidectomized rats fed a low calcium diet. Primary metaphyseal trabeculae in Cl2MDP-treated rats were more numerous and longer than in controls. The light and electron microscopic appearance of osteoblasts, osteocytes and osteoclasts were unaltered by Cl2MDP. Bone alkaline phosphatase was significantly elevated in rats given Cl2MDP but adenosine triphosphatase activity was unchanged. Bone fat-free weight, fat-free minus
ash
weight, and bone calcium and phosphorus concentration were reduced significantly in rats given 10 mg/kg Cl2MDP compared to controls. Bone magnesium concentration was significantly elevated in rats given 10 mg/kg Cl2MDP. Serum calcium and phosphorus concentration were lower in Cl2MDP-treated rats. These results suggest that Cl2MDP is capable of altering bone remodeling, enzyme activity and mineral content, without significantly altering bone cell morphology, independent of the effects of
parathyroid hormone
, calcitonin, and dietary calcium.
...
PMID:Effect of dichloromethylene diphosphonate on morphology, enzyme activity, and ash content of bones of thyroparathyroidectomized rats. 14 84
Sham-operated and parathyroidectomized (PTX) rats were divided into two pair-fed groups, one on a normal mineral intake (0.5% Ca, 0.3% P), the other on a regimen low in phosphorus (0.5% Ca, 0.03% P). P depletion led to a drop in plasma P and urine P, a rise in plasma Ca and a marked rise in urine Ca, a drop in serum magnesium and a rise in urine Mg. The changes were more pronounced in the PTX animals, but final values were the same in both groups. Parallel bone-seeking isotope (85Sr, 177Lu, 237Np) studies in nonablated animals revealed an increase in the urinary nuclide output and in the urine/tibia ratio in P-deficient animals. Normal and primary bone osteocytes decreased and enlarged osteocytes increased as a result of P deficiency; osteoclasts and osteoblasts also increased. Bone composition showed a drop in
ash
content and a rise in water, with a light decrease in both Ca and P, and a corresponding rise in hydroxyproline and nitrogen in the P-deficient animals. The results are interpreted to mean that P-deficiency in the young growing rat leads to an increase in bone resorption which occurs also in the absence of
parathyroid hormone
(
PTH
). The fact that final values were similar in the control and PTX P-deficient animals suggests that steady-state regulation can also occur without
PTH
. Because P-deficiency leads to rapid hypercalcemia and rapid marked hypercalciuria, there may exist a mechanism for phosphate regulation which would then supersede Ca homeostasis. The change in serum and urine Mg levels may reflect a decrease in tubular Ca and Mg reabsorption associated with P-deficiency.
...
PMID:Phosphorus deficiency, parathyroid hormone and bone resorption in the growing rat. 95 82
The effect of dietary vitamin D levels on the response to iv injected
parathyroid hormone
(
PTH
) was studies in chicks fed one of three diets: D-deficient, Control-D (1.4IU cholecalciferol/g diet), or High-D (70 IU cholecalciferol/g diet) during the first 4 weeks post-hatching. Compared to chicks on Control-D diet, chicks on the D-deficient diet had significantly decreased plasma Ca levels at 2 and 4 weeks and increased plasma P levels at 17 and 21 days. The plasma Ca response to a low dose of
PTH
(15 USP U/100 g body wt) 1 hr postinjection was normal at 1 week, reduced at 2 weeks and absent at 4 weeks in D-deficient chicks. However, a 4-16-fold higher dose of
PTH
did elicit a significant, though subnormal, response in this group at 3 and 4 weeks. Chicks fed the D-deficient diet with 2.8% Ca, compared to 1.4% Ca, showed a near normal plasma Ca level and bone
ash
content and only a small increase in plasma P at 17 and 21 days. However, the plasma Ca response to 15 U
PTH
/100 g body wt in this group was significantly increased only at 17 days and not at 21 days. In contrast, the hyperphosphatemic response to
PTH
was not markedly diminished in the D-deficient group, and it was restored to Control-D levels in the D-deficienyt High Ca group. These data suggest that different mechanisms may be involved in the Ca and P responses.
...
PMID:Vitamin D, dietary calcium and parathyroid hormone interactions in chicks. 111 53
Chickens were adapted to either a high or low calcium intake and then subjected to an acute calcium deficiency by feeding ground yellow corn +/- phosphate. Hypocalcemia developed within 3-5 h in those chicks given the corn plus phosphate. The response was about equal in the high and low adapted animals suggesting that the effect was not mediated via regulatory factors such as
parathyroid hormone
or thyrocalcitonin intervention. Rather, it is suggested that the influence of phosphate is direct and may be due to an enhancement of calcium movement from the fluids to the bone. The high calcium adapted chicks also exhibited some hypocalcemia in response to eating corn without phosphate supplementation. This development, contrary to the other cases, appeared to be due to a lag in calcium regulating mechanisms. The low calcium adaptation did not seem to influence growth within the timespan used, but there was a significant reduction in bone
ash
values and of adrenal enlargement. Thus, it was evident that the low and high calcium diets were different in regards to calcium metabolism and it appears that the low calcium intake may have been stressful.
...
PMID:Hypocalcemic development in high and low calcium-adapted chicks during acute calcium deficiency. 126 39
In antrectomized (B-I) and control rats, bone mineralization, the fractional intestinal absorption of calcium, magnesium and phosphorus, the balances of these minerals, their serum concentration and renal excretion, together with serum gastrin, calciotropic hormones (
parathyroid hormone
, calcitonin, 1,25-dihydroxyvitamin D), and osteocalcin were assessed four months after surgery. B-I evoked hypogastrinemia, but no changes in the serum concentrations of minerals and calciotropic hormones, or urinary cyclic AMP. The major significant changes brought about by B-I were: (1) a decrease in bone dry weight, specific density, bone
ash
calcium and magnesium content; (2) a decrease in the fractional absorption and urinary excretion of calcium and magnesium; (3) an increase in urinary hydroxyproline and serum osteocalcin in the presence of normal serum bone isoenzyme of alkaline phosphatase. It is concluded that in the rat (1) B-I over the long term decreases both bone mineral content and calcium and magnesium absorption, in the absence of any counterregulation; (2) B-I rats may have attained a new equilibrium which is characterized by decreased absorption and urinary excretion of calcium and magnesium, but maintenance of normocalcemia at the expense of bone; (3) the concomitant changes of serum bone markers are contradictory, which makes their interpretation and use in the present context difficult.
...
PMID:Disturbances of mineral and bone metabolism following gastric antrectomy in the rat. 133 20
Verapamil inhibits the intestinal absorption of calcium (Ca) and increases serum
parathyroid hormone
in rats. The effects of verapamil on bone tissue after long-term treatment is, however, not well described. Adult female and male Sprague-Dawley rats received verapamil in their drinking water at a dosage of 0.075 mg/ml (low dose) or 0.75 mg/ml (high dose) for 12 weeks; control rats received only drinking water. All rats were fed a diet containing 0.1% Ca and 0.5% P. In female rats, the amount of bone
ash
per volume was significantly reduced from 0.742 g/ml in controls to 0.713 g/ml after low-dose treatment of verapamil, and to 0.667 g/ml following high-dose treatment (P less than 0.01). The tibial length was increased from 39.7 mm in controls to 40.3 mm or to 40.7 mm after low or high doses (P less than 0.01). The tibial volume increased from 0.385 ml in controls to 0.397 ml after low doses and to 0.429 ml after high doses (P less than 0.01). In contrast, in male rats the amount of bone
ash
per volume was significantly increased from 0.578 g/ml in controls to 0.580 g/ml after low doses and to 0.620 g/ml after high doses of verapamil (P less than 0.01). The tibial bone volume in males as decreased from 0.633 ml in controls to 0.641 ml after low doses and to 0.583 ml after high doses (P less than 0.05). The tibial length in the males was not changed by verapamil.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Verapamil induces increased bone volume and osteopenia in female rats but has the opposite effect in male rats. 152 9
Seventy-two crossbred wether lambs (average initial weight, 25.1 kg) were used to determine the interaction between zeranol treatment and two dietary levels of Ca and P (.8 and .6% vs .4 and .3% Ca and P, respectively) in a 2 x 2 factorial arrangement on performance, carcass and bone characteristics, and serum concentrations of
parathyroid hormone
(
PTH
) and Ca. Lambs were implanted on d 0 and 56 with 12 mg of zeranol. Lambs had ad libitum access to feed for 105 d. On d 99, blood samples were collected. Implanted lambs had 12% greater (P less than .01) daily feed intake, 26% greater (P less than .10) ADG, and a 12% improvement in (P less than .10) feed efficiency compared with nonimplanted lambs. Zeranol-treated lambs had increased (P less than .05) bone cortical area, breaking load, and width of the metacarpal compared with nonimplanted lambs. Lambs fed the .8% Ca and .6% P diet had a higher (P less than .05) percentage of bone
ash
than lambs fed the .4% Ca and .3% P diet. However, there were no differences (P greater than .05) in the percentage of Ca, P, Mg, or Zn in metacarpal bones due either to higher dietary Ca and P or to implant treatments. Serum concentration of
PTH
was greater (P less than .10) in lambs fed .8% Ca and .6% P than in those receiving .4% Ca and .3% P. Serum concentrations of
PTH
and Ca pooled across treatments were greater (P less than .05) before feeding than at 1 h after feeding.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Effects of zeranol and two dietary levels of calcium and phosphorus on performance, carcass and bone characteristics, and calcium status in growing lambs. 152 3
The object of this study was to investigate whether a calcium-deficient diet increases the bone loss produced by mechanical hypofunction (disuse) in the rat. Male Sprague-Dawley rats of approximately 150 g were placed on either a normal diet or a calcium-deficient diet. After 7 days, all rats underwent unilateral hind-limb immobilization by sciatic neurectomy and were sacrificed 30 hours, 72 hours, or 10 days postsurgery. Femora were ashed and the total mineral content (
ash
weight) was determined. Tibiae were embedded, sectioned, and stained. The metaphyseal secondary spongiosa and the diaphyseal cortical bone were subjected to histomorphometric analysis. Femoral length and serum calcium were not affected by calcium intake or immobilization. Serum
parathyroid hormone
levels were elevated in rats on the calcium-deficient diet compared to those on the normal diet. Calcium deficiency caused a significant reduction in femoral
ash
weight (20-35%), tibial cortical thickness (16-20%), and trabecular bone volume (TBV) (33-39%) at 72 hours and 10 days postsurgery. Additional loss of bone mass occurred in the immobilized limb compared to the contralateral intact limb of both dietary groups. This loss occurred earlier (30 hours postsurgery versus 72 hours) in the animals on a calcium-deficient diet and was larger compared to animals on a normal diet (10.6% versus 4.8% at 72 hours and 17.9% versus 12.45% at 10 days). The total bone loss induced by the combination of a calcium-deficient diet and immobilization in this experiment was estimated to equal 46% of femoral
ash
weight and 79% of tibial TBV.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Immobilization-related bone loss in the rat is increased by calcium deficiency. 201 18
Magnesium (Mg) makes up 0.5-1% of bone
ash
and is therefore not a trace element in the skeleton. Mg influences both mineral and matrix metabolism in bone by a combination of effects on hormones and other factors that regulate skeletal and mineral metabolism, and by direct effects on bone itself. The skeletal content of Mg is very variable both between and within species, and reported values range between 150 and 440 mmol/kg
ash
weight (AW). Dietary Mg has a direct influence and age an inverse influence on skeletal Mg content. It is unclear whether skeletal Mg content varies from region to region. In humans, reported values cluster around the 200 mmol/kg AW level, 30-40% lower than most rat data. Human iliac crest cortical bone has 10-20% less Mg per unit weight than iliac crest trabecular bone. Mg depletion adversely affects all phases of skeletal metabolism. In the rat, cessation of bone growth is noted with a decrease in both osteoblast and osteoblast activity, decreased bone formation, osteopenia, increased fragility and development of a form of 'aplastic bone disease'. The epiphyseal growth plate is thinned and the percent
ash
weight of the growth plate is increased, possibly due to enhanced crystallization of bone salt under conditions of Mg depletion. In contrast, in chicks and in rats with severe Mg deficiency, these 'antianabolic' effects are not observed but instead, predominant inhibition of bone resorption occurs with increased cortical thickness rather than osteopenia, and the occasional development of subperiosteal hyperplasia or of fibrous tumors of the periosteum. It is probable that this unusual response under conditions of severe Mg deficiency is in part an indirect effect secondary to a defect in secretion and/or skeletal responsiveness to
parathyroid hormone
(
PTH
) and vitamin D metabolites. Mg excess also has adverse biologic effects on bone. Crystallization of bone salt is severely impaired and an osteomalacia-like picture may be produced with decreased osteoblastic activity, widened growth plates, excessive osteoid seams and short, thickened bones. In some studies, especially in mice, Mg excess stimulates bone resorption, independently of
PTH
. The role of Mg deficiency and excess in human skeletal conditions requires more extensive investigation. Bone Mg is uniformly increased in renal insufficiency and may play a role in renal osteodystrophy since improvement has been noted in the osteomalacic component by normalizing the serum Mg. Decreased bone Mg has been reported in alcoholic patients, diabetes and in osteoporosis.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Effects of magnesium on skeletal metabolism. 218 30
Bone turnover in T-cell deficient mice was investigated by comparing parameters of bone physiology in athymic (nude) and euthymic mice. Static and dynamic bone histomorphometry, serum biochemical assays, body weight and tibia length measurements, and bone
ash
determination were completed in 6- and 12-wk-old athymic (nude) mice (NIH: Swiss nu/nu) and euthymic mice (nu/+) (10 mice/group). In vitro bone resorbing activity stimulated by
parathyroid hormone
(
PTH
) or prostaglandin E2 (PGE2) was measured in calvaria of neonatal athymic and euthymic mice. Athymic mice had smaller vertebral tissue area (p less than 0.01), tibia length (p less than 0.001), and less body weight (p less than 0.01) than euthymic mice. The percent double labeled surface (p less than 0.05) and mineralizing perimeter (p less than 0.01) were reduced in athymic as compared to age-matched euthymic mice. Osteoclast number was reduced in the 6-wk athymic mice as compared to 6-wk euthymic mice. Osteoclastic perimeter was reduced in the 12-wk-old mice (athymic and euthymic) as compared to the 6-wk-old mice. Serum calcium was lower at both ages in athymic mice (p less than 0.01) as compared to euthymic mice. Serum alkaline phosphatase levels were reduced (p less than 0.01) in 12-wk-old athymic mice as compared to age-matched euthymic mice, and were greater in 6-wk-old mice than 12-wk-old mice. Athymic mice had greater femur density than euthymic mice (p less than 0.01), and lower (p less than 0.001) percent
ash
weight of dry bone compared to euthymic mice.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:A comparison of bone turnover in athymic (nude) and euthymic mice: biochemical, histomorphometric, bone ash and in vitro studies. 273 53
1
2
3
4
5
6
7
8
Next >>